Table I.
Descriptive Statistics for 99 Women with Metastatic Breast Cancer.
| Measure | 25th | Percentile Median (50th) or % | 75th |
|---|---|---|---|
| Demographics | |||
| Age at Baseline (years) | 47 | 54 | 62 |
| Age at Initial Diagnosis | 42 | 47 | 53 |
| Age at Metastasis/Recurrence | 45 | 51 | 58 |
| Ethnicity (% Caucasian) | 85.7 | ||
| Education | |||
| High School Diploma or Below | 2.0 | ||
| Trade School or Some College | 34.3 | ||
| Bachelor’s Degree | 20.2 | ||
| Some Graduate School or Master’s | 39.4 | ||
| Ph.D., M.D. or J.D. | 4.0 | ||
| Income (%) | |||
| < $20,000 | 5.6 | ||
| $20,000–$39,999 | 20.2 | ||
| $40,000–$59,999 | 12.4 | ||
| $60,000–$79,999 | 18.0 | ||
| $80,000–$99,999 | 13.5 | ||
| $100,000 and Above | 30.3 | ||
| Marital Status (%) | |||
| Single/Never Married | 7.1 | ||
| Married/Living as Married | 67.7 | ||
| Separated, Divorced, or Widowed | 25.3 | ||
| Employment Status (%) | |||
| Full Time | 22.2 | ||
| Part Time | 12.1 | ||
| Retired/Not Employed | 65.7 | ||
| Medical Status | |||
| Disease-Free Interval | 14 | 37 | 84 |
| Time DX to Study Entry (Months) | 30 | 77 | 116 |
| Time Metastasis to Study Entry (Months) | 7 | 13 | 36 |
| Estrogen Receptor Status (% Negative) | 29.3 | ||
| Progesterone Receptor Status (% Negative) | 31.5 | ||
| Site of Metastasis/Recurrence | |||
| Chestwall | 35.5 | ||
| Bone | 22.6 | ||
| Viscera | 41.9 | ||
| Treatment (% Yes) | |||
| Surgery | 93.8 | ||
| Reconstruction | 25.8 | ||
| Chemotherapy | |||
| Within 2 months of baseline | 14.3 | ||
| Radiation | |||
| Within 2 months of baseline | 12.2 | ||
| Hormone Therapy | |||
| Within 2 months of baseline | 29.6 | ||
| Antidepressant Use at Baseline | 40.2 | ||
| History of: | |||
| Diabetes | 3.1 | ||
| Stroke | 1.0 | ||
| Hypertension | 17.3 | ||
| Heart Disease | 3.1 | ||
| Smoking | 5.1 | ||